Cellmic Patent Aims to Grow Leti Portfolio

Facebook X LinkedIn Email
Leti, a research institute at CEA Tech, and Cellmic LLC, a company that leverages patient health care with smartphones and biophotonics, have joined forces to accelerate the market adoption of lens-free imaging and sensing techniques by growing Leti’s patent portfolio with a core patent from Cellmic.

Pioneered by Aydogan Ozcan, co-founder of Cellmic and Chancellor’s Professor at UCLA, and his research group, this patented computational lens-free imaging approach reconstructs detailed images of specimens from their holographic shadows that contain unique 3D information of samples, such as tissue sections, blood smears, and cell cultures. Cellmic LLC, a UCLA spinoff, holds some of the core patents of this important computational imaging technique.

Lens-free microscopy has emerged as a powerful imaging and sensing platform that replaces bulky and expensive optical components found in standard optical microscopy systems with dedicated algorithms. Leti developed a lens-free microscope in 2012. Today the technology offers an ultrawide field of view, tracking more than 10,000 biological, microscopic objects at a time per image, providing lab technicians with a cost-effective, highly compact, and robust solution. The Cellmic patent complements Leti’s IP portfolio and accelerates its ongoing valorization of its lens-free technology for diagnostics, biomedical sensing, and related applications.

“Lens-free, on-chip imaging offers a unique opportunity to bring advanced microscopy and sensing tools into your pocket with a fraction of the cost of existing technologies,” Ozcan said. “We are proud to have made fundamental contributions to establish this technique, which has been benefiting researchers in both academia and industry at a global scale.”

Leti is a leader in miniaturization technologies that enable smart, energy-efficient, and secure solutions for industry.

“Our partnership with Leti will help this powerful imaging and sensing technology to reach different markets through Leti’s powerful collaborations with other companies in various industries,” said Neven Karlovac, CEO and co-founder of Cellmic.

“Ozcan’s research lab and Cellmic have done groundbreaking work in developing lens-free imaging techniques,” said Jean-Marc Dinten, imaging department manager at Leti. “This core patent complements our lens-free technology development, [for applications] such as point-of-care diagnosis for spinal meningitis.”

Published: May 2018
BusinessLETICEA TechCellmicpartnershipsImagingOpticsSensors & DetectorsEuropeRapidScan

We use cookies to improve user experience and analyze our website traffic as stated in our Privacy Policy. By using this website, you agree to the use of cookies unless you have disabled them.